DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Loibl S, Untch M, Burchardi N. et al
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple negative breast cancer – clinical results and biomarker analysis of GeparNuevo study.
Ann Oncol 2019; pii: mdz158
DOI: 10.1093/annonc/mdz158.
We do not assume any responsibility for the contents of the web pages of other providers.